Pacific Shuanglin Bio-pharmacy Co., LTD (SHE: 000403)
China
· Delayed Price · Currency is CNY 22.90
-0.69 (-2.93%)
Oct 11, 2024, 3:04 PM CST
Pacific Shuanglin Bio-pharmacy Co., LTD Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | Jan '20 Jan 1, 2020 | 2019 - 2015 |
| Net Income | 795.96 | 612.11 | 587.13 | 391.06 | 185.97 | 160.45 | Upgrade
|
| Depreciation & Amortization | 137.1 | 142.74 | 126.39 | 115.76 | 47.37 | 46.3 | Upgrade
|
| Other Amortization | 5.6 | 3.37 | 4.43 | 7.39 | 8.36 | 8.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.13 | 0.54 | -0.44 | -0.27 | -0.02 | 0.36 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.32 | 1.29 | 3.59 | 103.67 | 5.27 | 2.52 | Upgrade
|
| Loss (Gain) From Sale of Investments | -19.98 | -17.56 | -7.97 | -77.91 | - | -6.65 | Upgrade
|
| Provision & Write-off of Bad Debts | 5.06 | -2.04 | 9.66 | 9.44 | -3.69 | 7.59 | Upgrade
|
| Other Operating Activities | -12.98 | -14.95 | -38.62 | -33.92 | -1.24 | 19.1 | Upgrade
|
| Change in Accounts Receivable | 40.11 | 274.65 | -329.07 | -196.58 | -89.04 | -125.84 | Upgrade
|
| Change in Inventory | -248.59 | -285.42 | 115.51 | 1.72 | -37.11 | -17.22 | Upgrade
|
| Change in Accounts Payable | -68.74 | -31.26 | 70.94 | 70.06 | 57.62 | 96.39 | Upgrade
|
| Change in Other Net Operating Assets | - | 2.23 | 10.6 | 21.65 | 22.44 | - | Upgrade
|
| Operating Cash Flow | 635.48 | 679.01 | 524.22 | 408.22 | 194.84 | 190.84 | Upgrade
|
| Operating Cash Flow Growth | 40.48% | 29.53% | 28.42% | 109.51% | 2.09% | 63.62% | Upgrade
|
| Capital Expenditures | -349.78 | -377.27 | -378.64 | -326.16 | -40.18 | -41.11 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.71 | 1.65 | 0.45 | 1.35 | 0.09 | 1.32 | Upgrade
|
| Cash Acquisitions | - | - | - | 64.57 | - | - | Upgrade
|
| Investment in Securities | -264.2 | 16.66 | -259.36 | -160 | - | - | Upgrade
|
| Other Investing Activities | 78.96 | 69.75 | 81.18 | -258.03 | -262.71 | 10 | Upgrade
|
| Investing Cash Flow | -533.31 | -289.21 | -556.38 | -678.28 | -302.81 | -29.8 | Upgrade
|
| Long-Term Debt Issued | - | 438.32 | 481.79 | 303.16 | 477.06 | 9.84 | Upgrade
|
| Total Debt Issued | 371.59 | 438.32 | 481.79 | 303.16 | 477.06 | 9.84 | Upgrade
|
| Long-Term Debt Repaid | - | -316.89 | -263.4 | -833.63 | -235 | -70 | Upgrade
|
| Total Debt Repaid | -319.06 | -316.89 | -263.4 | -833.63 | -235 | -70 | Upgrade
|
| Net Debt Issued (Repaid) | 52.53 | 121.43 | 218.39 | -530.47 | 242.06 | -60.16 | Upgrade
|
| Issuance of Common Stock | 22.54 | 8.3 | 2.51 | 1,597 | 35.2 | - | Upgrade
|
| Repurchase of Common Stock | - | -24.23 | -21.98 | - | - | - | Upgrade
|
| Common Dividends Paid | -215.76 | -66.79 | -49.66 | -12.05 | -178.84 | -144.61 | Upgrade
|
| Other Financing Activities | -1.17 | -0.47 | -0.8 | 1.76 | -1.76 | - | Upgrade
|
| Financing Cash Flow | -141.87 | 38.24 | 148.46 | 1,056 | 96.66 | -204.77 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.09 | -0.02 | -1.19 | -0.23 | - | - | Upgrade
|
| Net Cash Flow | -39.79 | 428.01 | 115.11 | 785.52 | -11.31 | -43.72 | Upgrade
|
| Free Cash Flow | 285.7 | 301.74 | 145.58 | 82.06 | 154.66 | 149.73 | Upgrade
|
| Free Cash Flow Growth | 2410.23% | 107.27% | 77.40% | -46.94% | 3.29% | 83.46% | Upgrade
|
| Free Cash Flow Margin | 10.37% | 12.96% | 6.05% | 4.16% | 14.73% | 16.35% | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.41 | 0.20 | 0.12 | 0.32 | 0.31 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 144.61 | Upgrade
|
| Cash Income Tax Paid | 223.4 | 213.87 | 172 | 148.92 | 71.87 | 69.67 | Upgrade
|
| Levered Free Cash Flow | 181.46 | 186.77 | -7.27 | -289.45 | 36.62 | -105.84 | Upgrade
|
| Unlevered Free Cash Flow | 188.1 | 192.79 | 0.25 | -282.71 | 48.69 | -92.27 | Upgrade
|
| Change in Net Working Capital | 136.35 | -25.66 | 127.58 | 365.67 | 124.13 | 225.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.